{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T13:37:01Z","timestamp":1782653821718,"version":"3.54.5"},"reference-count":45,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic><jats:bold>Background:<\/jats:bold><\/jats:italic>Pharmacists have become an integral member of the multidisciplinary team providing clinical patient care in various healthcare settings. Although evidence supporting their role in the care of patients with other disease states is well-established, minimal literature has been published evaluating pharmacist interventions in stroke patients. The purpose of this systematic review is to summarize the evidence evaluating the impact of pharmacist interventions on stroke patient outcomes.<jats:italic><jats:bold>Methods<\/jats:bold><\/jats:italic>: Study abstracts and full-text articles evaluating the impact of a pharmacist intervention on outcomes in patients with an acute stroke\/transient ischemic attack (TIA) or a history of an acute stroke\/TIA were identified and a qualitative analysis performed.<jats:italic><jats:bold>Results<\/jats:bold><\/jats:italic>: A total of 20 abstracts and full-text studies were included. The included studies provided evidence supporting pharmacist interventions in multiple settings, including emergency departments, inpatient, outpatient, and community pharmacy settings. In a significant proportion of the studies, pharmacist care was collaborative with other healthcare professionals. Some of the pharmacist interventions included participation in a stroke response team, assessment for thrombolytic use, medication reconciliation, participation in patient rounds, identification and resolution of drug therapy problems, risk-factor reduction, and patient education. Pharmacist involvement was associated with increased use of evidence-based therapies, medication adherence, risk-factor target achievement, and maintenance of health-related quality of life.<jats:italic><jats:bold>Conclusions<\/jats:bold><\/jats:italic>: Available evidence suggests that a variety of pharmacist interventions can have a positive impact on stroke patient outcomes. Pharmacists should be considered an integral member of the stroke patient care team.<\/jats:p>","DOI":"10.1017\/cjn.2017.233","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T09:20:07Z","timestamp":1505899207000},"page":"49-55","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacists as Care Providers for Stroke Patients: A Systematic Review"],"prefix":"10.1017","volume":"45","author":[{"given":"Jade E.","family":"Basaraba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"George-Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Mysak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"S0317167117002335_ref39","first-page":"CD000197","article-title":"Organised inpatient (stroke unit) care for stroke","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"S0317167117002335_ref1","unstructured":"Canadian Stroke Best Practices. Important Findings Released Today at the Canadian Stroke Congress. Ottawa: Heart and Stroke Foundation of Canada; 2014. Available at: http:\/\/www.strokebestpractices.ca\/index.php\/news\/the-5th-canadian-stroke-congress\/."},{"key":"S0317167117002335_ref43","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A158"},{"key":"S0317167117002335_ref21","unstructured":"Scott JS , Sampson EF , D\u2019Amato T . Self-medication in hospitalized stroke patients: effectiveness of medication counseling for right and left hemiplegics [abstract]. Presented at the Annual Meeting of the American Society of Health-System Pharmacists; 1989: P-32E."},{"key":"S0317167117002335_ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-009-9315-y"},{"key":"S0317167117002335_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2011.11.013"},{"key":"S0317167117002335_ref33","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318284056a"},{"key":"S0317167117002335_ref23","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.140053"},{"key":"S0317167117002335_ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181e57962"},{"key":"S0317167117002335_ref14","doi-asserted-by":"crossref","unstructured":"Hohmann C , Klotz JM , Radziwill R . Drug-related problems in patients at a stroke unit [abstract]. In: 19th European Stroke Conference Abstracts; 2010 May 25-28; Barcelona, Spain. Cerebrovasc Dis 2010;29(suppl 2):A220.","DOI":"10.1159\/000315008"},{"key":"S0317167117002335_ref27","unstructured":"Bruner L . Stroke bridge clinic: aiming at reduced readmissions for newly diagnosed stroke and complicated TIA patients [abstract]. Presented at the American Society of Health-System Pharmacists Summer Meeting; 2012 Jun 9-13; Baltimore, USA."},{"key":"S0317167117002335_ref41","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.22.4.241"},{"key":"S0317167117002335_ref35","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e31823f232d"},{"key":"S0317167117002335_ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00940.x"},{"key":"S0317167117002335_ref37","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp110004"},{"key":"S0317167117002335_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.08.001"},{"key":"S0317167117002335_ref4","unstructured":"Gosford CR , Hardeo S , Rizzo S , Fox S . Impact of door to alteplase (tPA) time with around the clock pharmacist response to code gray [abstract]. In: ASHP 2011 Midyear Clinical Meeting Professional Poster Abstracts; 2011 Dec 4-8; New Orleans, USA. 2012: A3092."},{"key":"S0317167117002335_ref44","first-page":"4","volume-title":"Canadian Best Practice Recommendations for Stroke Care","author":"Casaubon","year":"2013"},{"key":"S0317167117002335_ref31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.18553\/jmcp.2007.13.1.28","article-title":"Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review","volume":"13","author":"Horning","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"S0317167117002335_ref3","first-page":"E209","article-title":"Implementation of a central page activation for acute ischemic strokes","volume":"40","author":"Bellolio","year":"2009","journal-title":"Stroke"},{"key":"S0317167117002335_ref40","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.955"},{"key":"S0317167117002335_ref26","doi-asserted-by":"crossref","unstructured":"Hooker AF , Evans H . Does stroke bridge clinic reduce hospital readmission rates in patients who have suffered a stroke [abstract]. In: International Stroke Conference and Nursing Symposium Poster Abstracts; 2012 Feb 1-3; New Orleans, USA. Stroke. 2012;43:A2480.","DOI":"10.1161\/str.43.suppl_1.A2480"},{"key":"S0317167117002335_ref12","first-page":"200","article-title":"Role of the clinical pharmacist in reducing decision-to-needle tPA times during code stroke in the emergency department","volume":"26","author":"Brandon","year":"2013","journal-title":"J Pharm Pract"},{"key":"S0317167117002335_ref19","doi-asserted-by":"crossref","unstructured":"Tsai YJ , Leu WJ , Lin YM , Lu TH . Pharmacist\u2019s involvement in a multidisciplinary ischemic stroke team in and its associated cost avoidance [abstract]. In: ISPOR 5th Asia-Pacific Conference; 2012 Sep 2-4; Taipei, Taiwan. Value Health. 2012;15(7):A632.","DOI":"10.1016\/j.jval.2012.08.189"},{"key":"S0317167117002335_ref30","doi-asserted-by":"publisher","DOI":"10.1300\/J055v08n01_04"},{"key":"S0317167117002335_ref25","doi-asserted-by":"crossref","unstructured":"Nguyen VV , Poon J , Tokuda L , Sayers J , Wallis R , Dergalust S . Pharmacist telephone interventions improve adherence to stroke preventive medications and reduce stroke risk factors: a randomized controlled trial [abstract]. In: International Stroke Conference and Nursing Symposium Poster Presentations presented at the International Stroke Conference; 2011 Feb 9-11; Los Angeles, USA. Stroke. 2011; 42:AWP302.","DOI":"10.1161\/STR.0b013e3182074d9b"},{"key":"S0317167117002335_ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-012-9690-7"},{"key":"S0317167117002335_ref8","doi-asserted-by":"crossref","unstructured":"Garland J . Achieving target: stroke honor roll status through the utilization of 9 best practice strategies [abstract]. In: Abstracts from the American Heart Association\/American Stroke Association 2013 International Stroke Conference and Nursing Symposium; 2013 Feb 5-8; Honolulu, USA. Stroke. 2013;44:AWP359.","DOI":"10.1161\/str.44.suppl_1.AWP359"},{"key":"S0317167117002335_ref15","first-page":"8","article-title":"An audit of the pharmacological management of ischaemic stroke patients in a metropolitan Australian hospital. Int","volume":"37","author":"Khalil","year":"2015","journal-title":"J Clin Pharm"},{"key":"S0317167117002335_ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000369380"},{"key":"S0317167117002335_ref20","unstructured":"Sreenivasan B . Inpatient stroke education in a rehabilitation hospital: patient evaluation [abstract]. In: 7th World Congress for Neurorehabilitation; 2012 May 16-19; Melbourne, Australia. Neurorehabil Neural Repair 2012;26(6):A321."},{"key":"S0317167117002335_ref22","first-page":"431","article-title":"Integration of a pharmacist into a stroke prevention clinic team","volume":"61","author":"Lindblad","year":"2008","journal-title":"Can J Hosp Pharm"},{"key":"S0317167117002335_ref16","first-page":"671","article-title":"Development and evaluation of hospital referrals for the new medicines service","volume":"22","author":"Barnett","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"S0317167117002335_ref42","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp120221"},{"key":"S0317167117002335_ref5","unstructured":"Murray S , Noviasky J . Emergency department pharmacist impact on tissue plasminogen activator (tPA) administration: time to administration and dose accuracy [abstract]. Presented at the ASHP Midyear Clinical Meeting; 2010; Anaheim, USA."},{"key":"S0317167117002335_ref32","first-page":"CD000213","article-title":"Thrombolysis for acute ischaemic stroke","author":"Wardlaw","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"S0317167117002335_ref28","unstructured":"Lee J , Graham C , Silliman S , Merino-Juarez J . Evaluation of stroke patients\u2019 knowledge of their medications [abstract]. Presented at the ASHP Midyear Clinical Meeting; 2004 Dec 4-8; Orlando, USA: A121E."},{"key":"S0317167117002335_ref7","doi-asserted-by":"crossref","unstructured":"Steiner NE , Wolber N , Robertson B , Rosenfield P , Paletz L . A team approach for improving door to needle time for IV t-PA in acute stroke [abstract]. In: Abstracts from the American Heart Association\/American Stroke Association 2013 International Stroke Conference and Nursing Symposium; 2013 Feb 5-8; Honolulu, USA. Stroke. 2013;44:ATP362.","DOI":"10.1161\/str.44.suppl_1.ATP362"},{"key":"S0317167117002335_ref9","doi-asserted-by":"crossref","unstructured":"Spokoyny I , Raman R , Ernstrom K , et al. Expedited code stroke protocol: an updated experience [abstract]. In: 2014 Annual Meeting of the American Academy of Neurology; 2014 Apr 26-May 3; Philadelphia, USA. Neurology. 2014;82(1):S35.002.","DOI":"10.1212\/WNL.82.10_supplement.S35.002"},{"key":"S0317167117002335_ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-549"},{"key":"S0317167117002335_ref6","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090616"},{"key":"#cr-split#-S0317167117002335_ref34.1","unstructured":"15. Lindsay MP, Gubitz G, Bayley M, et al. Canadian Best Practice Recommendations for Stroke Care, Updated 2010. On behalf of the Canadian Stroke Strategy Best Practices and Standards Writing Group. Ottawa: Canadian Stroke Network"},{"key":"#cr-split#-S0317167117002335_ref34.2","unstructured":"16. 2010. Available at: http:\/\/www.strokebestpractices.ca\/index.php\/news\/the-5th-canadian-stroke-congress\/."},{"key":"S0317167117002335_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.04.011"},{"key":"S0317167117002335_ref18","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.678847"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167117002335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T03:03:12Z","timestamp":1719457392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167117002335\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0317167117002335"],"URL":"https:\/\/doi.org\/10.1017\/cjn.2017.233","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]}}}